Oncology Nutrition Market – Trends Forecast Till 2030

Market Snapshot

Market Overview

The global Oncology Nutrition Market size was estimated at USD 2,210 million in 2023 and is projected to reach USD 3,279.3 million in 2030 at a CAGR of 9.8% during the forecast period 2024-2030.

The oncology nutrition market is a rapidly growing sector within the healthcare and pharmaceutical industries, driven by the increasing prevalence of cancer worldwide. As cancer cases rise, the need for effective nutritional management to support patients undergoing treatment has gained significant attention. Oncology nutrition focuses on providing tailored dietary solutions to cancer patients to help manage side effects of treatments like chemotherapy, radiation, and surgery, which can lead to malnutrition, weight loss, and other complications. This market includes specialized formulas, enteral nutrition, and parenteral nutrition products designed to address the specific nutritional needs of cancer patients.

The scope of the oncology nutrition market is broad, encompassing a range of products aimed at improving the nutritional status and overall well-being of cancer patients. These products are categorized into standard, elemental, and specialized formulas, with each designed to meet different nutritional requirements based on the patient's condition, type of cancer, and stage of treatment. Enteral nutrition (delivered via feeding tubes) and parenteral nutrition (administered intravenously) are two primary methods of nutritional support. Additionally, the market extends to various distribution channels, including hospital pharmacies, retail pharmacies, and online platforms, making these products accessible to a wide range of consumers.

Drivers of growth in the oncology nutrition market include increasing awareness of the importance of nutritional care in cancer treatment, advances in nutrition science, and the growing adoption of specialized feeding solutions. Additionally, the rising number of cancer patients globally, particularly in developing regions, has led to a greater demand for nutritional interventions. Healthcare providers and cancer centers are recognizing the critical role of proper nutrition in improving treatment outcomes and quality of life, further driving the adoption of oncology nutrition products. Increasing healthcare expenditure, particularly in oncology care, also supports the growth of this market.

Trends in the oncology nutrition market reflect a shift toward personalized nutrition, with products being developed to address the specific needs of individual patients. Innovations in formula development, such as plant-based or immune-boosting ingredients, are becoming more prevalent, catering to patient preferences and requirements. Furthermore, the use of digital health technologies and telemedicine to monitor nutritional intake and progress is expected to play a larger role in managing oncology nutrition. The growing emphasis on patient-centred care and integrated treatment approaches also indicates that the market will continue to expand, offering more customized and holistic nutritional solutions for cancer patients.

Delvens Industry Expert's Standpoint

Experts in the oncology nutrition market highlight several key trends driving growth and innovation. The oncology nutrition market is growing rapidly due to the rising global prevalence of cancer and the increasing recognition of the importance of proper nutrition in supporting patients undergoing cancer treatments. This market includes specialized nutritional products like enteral and parenteral nutrition, along with standard, elemental, and specialized formulas tailored to meet the specific needs of cancer patients. Key drivers include the growing number of cancer cases, advancements in nutrition science, and the rising awareness of the role nutrition plays in improving treatment outcomes and quality of life. Trends in the market highlight a shift toward personalized nutrition, innovations in formula development, and the integration of digital health technologies, all aimed at providing more targeted and effective nutritional support for cancer patients.

Market Portfolio

Key Findings

• On the basis of cancer type, Oncology Nutrition Market is segmented into the head and neck cancers. This segment held the largest market share in 2017. Patients with these cancers often experience significant challenges with oral nutritional intake, leading to the use of enteral nutrition for support. As the number of head and neck cancer cases rises, the demand for tube feeding formulas has also increased. Additionally, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting further restrict the ability to consume adequate nutrition, driving the adoption of specialized oncology nutritional feeding formulas.

• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. Asia Pacific is projected to hold the largest market share. Factors such as rising cancer incidence, increasing awareness of nutritional care, advancements in nutrition science, growing adoption of personalized nutrition, supportive government policies, rising healthcare expenditure, availability of specialized nutritional formulas, improved patient outcomes with proper nutrition, technological advancements in nutrition delivery, have triggered the demand for oncology nutrition products in the region.

Regional Analysis

North America to Dominate the Market

• North America dominated the oncology nutrition market in 2022, driven by a well-established healthcare system, heightened awareness of advanced cancer care solutions, and significant investments in research and development of new therapeutics. The region’s strong infrastructure and ongoing advancements in cancer treatment contribute to its leadership in the market. According to the Canadian Cancer Society, Canada reported 239,100 new cancer cases and 86,700 cancer-related deaths in 2023, with 1 in 24 Canadians being diagnosed with cancer over the past 25 years, further highlighting the growing demand for oncology nutrition solutions.

• In Europe, the oncology nutrition market is expected to grow steadily from 2023 to 2031, driven by an increasing focus on personalized medicine and cancer care. Government policies and supportive guidelines are also playing a key role in advancing the market. According to the European Commission, cancer care is a significant financial burden on the European Union’s healthcare system, costing over EUR 100 billion annually, which underscores the growing need for specialized oncology nutrition solutions in the region.

Competitive Landscape

• Danone S.A.
• Pfizer Inc.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Grifols S.A.
• Baxter International, Inc.
• Nestle S.A.
• Abbott Laboratories
• AbbVie, Inc.
• Sichuan Kelun Pharmaceutical Co., Ltd.

Recent Developments

• In January 2024, Danone formed a partnership with Resilience, a digital oncology company, to enhance nutritional care for cancer patients. This collaboration focuses on creating an innovative nutrition and oncology module that will be integrated with Resilience's digital oncology platform.

• In July 2022, Nestle introduced China's first Foods for Special Medical Purpose (FSMP), specifically developed for patients with tumour-related conditions. The product followed a comprehensive five-year approval process with Chinese regulatory authorities.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
• Gain authentic and granular data access for the Oncology Nutrition Market to understand the trends and the factors involved in changing market situations.
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope